Description
Tirzepatide is a once‑weekly, subcutaneous injectable medication used for type 2 diabetes, chronic weight management, and obesity‑related obstructive sleep apnea (OSA). It works by activating both GIP and GLP‑1 receptors, offering dual‑pathway metabolic benefits.
Reviews
There are no reviews yet.